Knowledge (XXG)

Malignancy

Source 📝

71: 1767: 1779: 563:
Lung cancer has the highest mortality rate in comparison to other forms of cancer, with the leading cause of development due to smoking. The number of smokers in China is rapidly increasing with tobacco killing approximately 3000 people each day. The diagnosis of lung cancer is most common within the
469:
Malignancy can be treated through the use of hyperthermia by applying either surgical perfusion or interstitial techniques to the body. The use of this treatment type largely depends on the fact that malignant and normal cells have differing responses to the energy source used. This dependency is due
399:
Surgery can help manage or treat malignancy by either removing the tumour, localising it and/or determining whether there has been a spread to other organs. When undertaking surgery for malignancy, there are six major objectives which are considered. These include "prevention of cancer, diagnosis and
324:
can also play a role in triggering malignancy as it can promote stages of tumour formation. The main purpose of inflammation is to repair tissue, defend the body against pathogens and regenerate cells. At the same time, inflammatory cells can also interact with malignant cells to form an inflammatory
277:
When malignant cells form, symptoms do not typically appear until there has been a significant growth of the mass. Once signs and symptoms do arise, they are dependent on the location, size and type of malignancy. Usually, it is quite general and can be associated with other illnesses or diseases and
434:(HPD) is a drug which was developed to be absorbed by malignant cells and only becomes active when exposed to light. It is commonly used to identify and localise cancers as when it is under activation of blue light the red fluorescence of the malignant tumour (due to the HPD) can be observed easily. 512:
which kill rapidly dividing cells within the body. It targets the cellular mechanisms which allow the development of malignancy throughout the body. There are no specific areas which are targeted and so, there is a lack of differentiation between normal and malignant cells, resulting in a range of
319:
have the ability to form an environment within states of chronic inflammation which gives rise to oncogenic potential. Viral agents are able to assist the formation of malignant tumours due to a mechanism of cell transformation. This cell transformation can occur through either "DNA integration or
559:
Malignancy has been a constant global health concern for a number of years, resulting in significant social and economic impacts on individuals with malignancy and their families. The risk of developing malignancy is 20.2%. In 2018, 18 million patients were diagnosed with a malignant tumour with
281:
Signs include observable or measurable aspects such as weight loss (without trying), a fever or unusual bleeding. On the other hand, symptoms are felt internally by the individual such as fatigue or changes in appetite. A general list of common signs and symptoms includes pain (headaches or bone
418:
Curative surgery (also known as primary surgery) can be conducted when the malignant tumour has only invaded one area of the body. The objective is to remove the entirety of the malignant cells without violating the tumour; if the tumour is violated, the risk of both tumour spillage and wound
268:
would then be required to make a diagnosis and distinguish whether the tumour is malignant or benign. This involves examination of a small sample of the tissue in a laboratory. If detected as a malignant tumour, treatment is necessary; treatment during early stages is most effective. Forms of
422:
The surgical procedure of tumour debulking can be undertaken to increase the effectiveness of postoperative forms of treatment. Symptom palliation and patient rehabilitation do not play a role in controlling or reducing malignancy growth rather, they increase the patient's quality of life.
415:. This process requires a sufficient amount of tissue to make a confident diagnosis and, the handling of specimen to expand information provided from testing. Biopsies are categorised into four different processes: "fine-needle aspirate (FNA), core needle, incisional and, excisional". 525:. Some side effects are specific to the anticancer drug used, the most common being bone marrow suppression as bone marrow has the ability to divide rapidly due to high growth fraction. This is because anticancer drugs have the highest activity in high growth fraction tissues. 362:". The different types of malignancy developed post-transplant depend on which organ was transplanted. This is linked to recipients being at a higher risk when exposed to traditional risk factors as well as, the type and intensity of the operation, the duration of their 571:
is the most frequent form of malignancy with the brain and nervous system subsequent. These individuals account for approximately 1% of the cancer mortality rate – about 110,000 children each year. In the 15–49-year-old age bracket the most common form of malignancy is
560:
lung, breast and prostate being the most common form. Additionally, there were approximately 10 million mortalities due to cancer in 2020 and, there is an overall trend which demonstrated that malignant mortality has increased by 28% over the past 15 years.
294:
Malignant cells often evolve due to a combination of reasons rather than one definitive reason. Reasons which can explain their development include genetics and family history, triggers such as infectious diseases, and exposure to risk factors.
221:
in more general medical use characterises a condition or growth that is not cancerous, i.e. does not spread to other parts of the body or invade nearby tissue. Sometimes the term is used to suggest that a condition is not dangerous or serious.
390:
are also used as treatment forms to kill or reduce malignant cells. A large portion of patients are at risk of death when diagnosed with malignancy as the disease has usually progressed for a number of years before detection.
341:
Traditional risk factors of developing malignancy include smoking, sun exposure and, having a history of cancer in the family. Other risk factors include developing post-transplant malignancy which occurs subsequent to solid
329:. This environment increases the likelihood of forming malignant cells through blockage of anti-tumour immunity. Once this occurs, the inflammatory tumour microenvironment begins to send out tumour-promoting signals to 449:
through the photodynamic process; where the oxygen molecule exists in an electronically excited state. The singlet oxygen is a cytotoxic agent which holds the ability to eradicate malignant cells by preventing both
403:
Surgical prevention of cancer largely consists of removing the organ at risk of developing malignancy. This would occur if an individual is predisposed to the formation of malignant cells as a result of inherited
306:
play a role in the development of malignancy, with agents of infectious disease being able to produce a multitude of malignant cells. These include bacterial causes, fungal and parasitic causes and, viral causes.
282:
aches), skin changes (new moles or bumps), coughing and unusual bleeding. There are also signs and symptoms specific to females including belly pain and bloating or breast changes i.e., the formation of a
482:
within each cell is affected indirectly and/or through multiple pathways. The combination of these intracellular changes means there is no specific target of cell death in the hyperthermic process.
493:
is commonly used as either the primary treatment or in conjunction with other treatment forms such as radiotherapy or surgery. It can be administered through "injection, intra-arterial (IA),
354:
Individuals who undergo organ transplant surgery have an increased risk of developing malignancy in comparison to the general population. The most common form of malignancy being "
535:
when reacting with DNA. This results in breaks within DNA strands causing either inter-strand or intra-strand DNA cross-linking. The sub-classes of alkylating agents are "
1601: 1276: 960: 210:
in that a malignancy is not self-limited in its growth, is capable of invading into adjacent tissues, and may be capable of spreading to distant tissues.
256:
Tumours can be detected through the visualisation or sensation of a lump on the body. In cases where there is no obvious representation of a lump, a
1232: 815: 458:. The treatment process also utilises HPD's capability of accumulating at higher levels in malignant tissues compared to most other tissues. 1403:
Papadimitraki ED, Bertsias G, Chamilos G, Boumpas DT (January 2011). "Systemic Lupus Erythematosus". Academic Press. pp. 1083–1108.
1362:
Hrycay EG, Bandiera SM (2015). "Involvement of Cytochrome P450 in Reactive Oxygen Species Formation and Cancer". In Hardwick JP (ed.).
190: 'born') is the tendency of a medical condition to become progressively worse; the term is most familiar as a characterization of 461:
In the case of deeply pigmented or larger tumours, a stronger course of this treatment process is required in order to be effective.
1416: 1379: 1294: 1253: 684: 359: 1757: 1799: 437:
The combination of HPD with red light (photoradiation) has been used on various malignant tumours including malignant
326: 123:
Smoking, sun exposure, genetics - history of malignancy, solid organ transplantation (post-transplant malignancy),
38: 968: 637: 514: 355: 238: 245:, containing multiple subclones. They also frequently have reduced expression of DNA repair enzymes due to 1460:
Christophi C, Winkworth A, Muralihdaran V, Evans P (1998). "The treatment of malignancy by hyperthermia".
1149:"Comparison of the incidence of malignancy in recipients of different types of organ: a UK Registry audit" 697: 656: 649: 146: 676: 343: 286:. Signs and symptoms specific to males include pain or growths in the scrotum or difficulty urinating. 241:, frequently have between 10,000 and 100,000 mutations in their entire genomes. Cancers usually show 242: 400:
staging of disease, disease cure, tumour debulking, symptom palliation and patient rehabilitation".
725: 303: 124: 269:
treatment include chemotherapy, surgery, photoradiation and hyperthermia, amongst various others.
1715: 1426: 1178: 1129: 784: 445:
on a range of different organs including the breast and colon. This form of treatment produces a
374:
There are various treatment forms available to help manage malignancy. Common treatments include
234: 105: 743: 1804: 1707: 1663: 1547: 1477: 1412: 1385: 1375: 1344: 1228: 1170: 1121: 1079: 1021: 911: 862: 811: 589: 536: 528: 455: 405: 363: 131: 93: 31: 1332: 1697: 1653: 1645: 1583: 1537: 1469: 1404: 1367: 1220: 1160: 1113: 1069: 1061: 1011: 901: 893: 852: 844: 518: 509: 1499: 1783: 1439: 766: 494: 431: 1331:
Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A (August 1978).
264:
can be used to determine the presence of a tumour. In the case of an existing tumour, a
1771: 1737: 1658: 1633: 1542: 1525: 1408: 1074: 1049: 906: 881: 857: 832: 663: 593: 446: 383: 179: 1473: 1215:
Donohue JH (2008). "Principles of cancer surgery.". In Norton JA, et al. (eds.).
1793: 1602:"Cancer data in Australia, cancer incidence and survival by stage data visualisation" 1165: 1148: 573: 532: 475: 471: 1182: 1133: 70: 939: 597: 577: 540: 490: 479: 451: 387: 375: 321: 214: 202: 150: 1719: 897: 110:
Fatigue, lump(s), change in skin, abnormal bleeding, prolonged cough, unexplained
1224: 1065: 848: 17: 1587: 1371: 585: 581: 502: 498: 283: 257: 246: 118: 111: 1766: 1016: 999: 1649: 1117: 548: 544: 442: 330: 230: 1741: 1364:
Cytochrome P450 Function and Pharmacological Roles in Inflammation and Cancer
564:
50–59-year age bracket. Further, it caused 1.8 million deaths in 2020 alone.
1733: 568: 438: 379: 316: 226: 83:) spreads uncontrollably and invades the surrounding tissues; benign tumor ( 1711: 1667: 1551: 1481: 1389: 1174: 1125: 1083: 1025: 915: 866: 531:
are used in chemotherapy as these are chemically reactive drugs which form
217:
has none of those properties, but may still be harmful to health. The term
1348: 604: 522: 308: 250: 98: 62: 670: 630: 366:
post-operation and, the risk of developing oncogenic viral infections.
1147:
Collett D, Mumford L, Banner NR, Neuberger J, Watson C (August 2010).
623: 470:
to the intracellular changes which occur during hyperthermia; as the
412: 265: 191: 136: 58: 1702: 1685: 312: 1104:
Rossi AP, Klein CL (February 2019). "Posttransplant Malignancy".
1050:"Inflammation and Cancer: Triggers, Mechanisms, and Consequences" 1333:"Photoradiation therapy for the treatment of malignant tumors" 261: 27:
Tendency of a medical condition to become progressively worse
882:"Intratumor heterogeneity: evolution through space and time" 644:
Non-oncologic disorders referred to as "malignant" include:
278:
thus, can be difficult to diagnose or can be misdiagnosed.
1366:. Advances in Pharmacology. Vol. 74. pp. 35–84. 998:
Callahan CM, Vincent AL, Greene JN, Sandin RL (May 1999).
584:
following. Finally, those aged 60 and over mainly develop
1574:
Lind MJ (2011). "Principles of cytotoxic chemotherapy".
1526:"Chemotherapy: managing side effects and safe handling" 810:. Lippincott Williams & Wilkins. pp. 858–869. 411:
Surgical diagnosis of malignancy involves completing a
1755: 806:
Wilkins EM (April 2008). "The Patient with Cancer".
333:
cells, triggering the formation of malignant cells.
320:
cellular-DNA alteration of growth regulator genes".
1271: 1269: 1267: 165: 157: 142: 130: 117: 104: 92: 54: 49: 1455: 1453: 1451: 1449: 961:"Signs and Symptoms of Cancer – Do I have cancer?" 808:Clinical Practice of the Dental Hygienist Workbook 1627: 1625: 1623: 1621: 1619: 1617: 1615: 1519: 1517: 1515: 1513: 1326: 1324: 1322: 1320: 1318: 1316: 87:) remains self-contained from neighbouring tissue 1500:"Chemotherapy: How it works and how you'll feel" 1493: 1491: 993: 991: 989: 987: 985: 539:, oxazaphosphorines, alkyl alkane, sulphonates, 37:"Malignant" redirects here. For other uses, see 1248: 1246: 1244: 1210: 1208: 1206: 1204: 1202: 1200: 1198: 1196: 1194: 1192: 1679: 1677: 1219:. New York, NY: Springer. pp. 1965–1984. 1043: 1041: 1039: 1037: 1035: 933: 931: 929: 927: 925: 1099: 1097: 1095: 1093: 719: 717: 715: 713: 233:. Malignant tumors are also characterized by 8: 1569: 1567: 1565: 1563: 1561: 1281:American Society of Clinical Oncology (ASCO) 1258:American Society of Clinical Oncology (ASCO) 965:American Society of Clinical Oncology (ASCO) 955: 953: 761: 759: 757: 249:methylation of DNA repair genes or altered 1606:Australian Institute of Health and Welfare 225:Malignancy in cancers is characterized by 69: 46: 1701: 1657: 1638:Journal of Epidemiology and Global Health 1541: 1164: 1073: 1015: 905: 856: 253:that control DNA repair gene expression. 940:"What are the different types of tumor?" 1762: 1686:"Epidemiology: The dominant malignancy" 1048:Greten FR, Grivennikov SI (July 2019). 709: 1632:Mattiuzzi C, Lippi G (December 2019). 1435: 1424: 508:The purpose of chemotherapy is to use 1106:The Surgical Clinics of North America 201:tumor contrasts with a non-cancerous 7: 1153:American Journal of Transplantation 1409:10.1016/B978-0-12-374994-9.10058-0 237:, so that cancers, as assessed by 25: 1277:"How Surgery Is Used for Cancer?" 1000:"Infectious Causes of Malignancy" 831:Tuna M, Amos CI (November 2013). 1777: 1765: 1166:10.1111/j.1600-6143.2010.03181.x 674:(malaria caused specifically by 1530:The Canadian Veterinary Journal 771:World Health Organization (WHO) 386:procedures. Photoradiation and 1498:Nazzario B (8 February 2021). 1299:NCI Dictionary of Cancer Terms 833:"Genomic sequencing in cancer" 685:Neuroleptic malignant syndrome 1: 1634:"Current Cancer Epidemiology" 1474:10.1016/s0960-7404(99)00007-9 898:10.1158/0008-5472.CAN-12-2217 567:In those aged 14 or younger, 419:implantation would increase. 360:lymphoproliferative disorders 1295:"Hematoporphyrin derivative" 1225:10.1007/978-0-387-68113-9_95 1066:10.1016/j.immuni.2019.06.025 938:Brazier Y (21 August 2019). 849:10.1016/j.canlet.2012.11.004 513:side effects. This includes 1684:Bender E (September 2014). 1588:10.1016/j.mpmed.2011.09.009 1372:10.1016/bs.apha.2015.03.003 787:. Mount Sinai Health System 748:National Cancer Institution 161:442.4 per 100,000 per year 1821: 1017:10.1177/107327489900600314 880:Swanton C (October 2012). 432:Hematoporphyrin derivative 350:Post-transplant malignancy 186: 'badly' and 39:Malignant (disambiguation) 36: 29: 1650:10.2991/jegh.k.191008.001 1524:MacDonald V (June 2009). 1254:"What is cancer surgery?" 1118:10.1016/j.suc.2018.09.004 671:Malignant tertian malaria 77: 68: 664:Malignant otitis externa 638:Malignant transformation 505:(IV), topical or oral". 408:and, acquired diseases. 603:Uses of "malignant" in 515:bone marrow suppression 356:nonmelanoma skin cancer 239:whole genome sequencing 698:Precancerous condition 657:Malignant hyperthermia 650:Malignant hypertension 344:organ transplantations 147:Photoradiation therapy 1504:WebMD – Cancer Centre 730:WebMD – Cancer Centre 677:Plasmodium falciparum 169:~10 million per year 785:"Benign Information" 773:. 21 September 2021. 622:are synonymous with 358:and, posttransplant 243:tumour heterogeneity 229:, invasiveness, and 1800:Medical terminology 744:"Cancer statistics" 304:Infectious diseases 125:infectious diseases 944:Medical News Today 724:Martin LJ (2020). 616:malignant neoplasm 273:Signs and symptoms 235:genome instability 30:For the band, see 1746:Our World in Data 1462:Surgical Oncology 1434:Missing or empty 1234:978-0-387-30800-5 892:(19): 4875–4882. 817:978-1-58255-838-7 726:"Cancer Symptoms" 537:nitrogen mustards 529:Alkylating agents 456:protein synthesis 406:genetic mutations 364:immunosuppression 173: 172: 132:Diagnostic method 79:Malignant tumor ( 44:Medical condition 32:Malignancy (band) 18:Malignant disease 16:(Redirected from 1812: 1782: 1781: 1780: 1770: 1769: 1761: 1750: 1749: 1730: 1724: 1723: 1705: 1681: 1672: 1671: 1661: 1629: 1610: 1609: 1598: 1592: 1591: 1571: 1556: 1555: 1545: 1521: 1508: 1507: 1495: 1486: 1485: 1457: 1444: 1443: 1437: 1432: 1430: 1422: 1400: 1394: 1393: 1359: 1353: 1352: 1343:(8): 2628–2635. 1328: 1311: 1310: 1308: 1306: 1291: 1285: 1284: 1273: 1262: 1261: 1260:. 31 March 2011. 1250: 1239: 1238: 1212: 1187: 1186: 1168: 1159:(8): 1889–1896. 1144: 1138: 1137: 1101: 1088: 1087: 1077: 1045: 1030: 1029: 1019: 995: 980: 979: 977: 976: 967:. Archived from 957: 948: 947: 935: 920: 919: 909: 877: 871: 870: 860: 828: 822: 821: 803: 797: 796: 794: 792: 781: 775: 774: 763: 752: 751: 740: 734: 733: 721: 519:gastrointestinal 510:cytotoxic agents 327:microenvironment 88: 73: 47: 21: 1820: 1819: 1815: 1814: 1813: 1811: 1810: 1809: 1790: 1789: 1788: 1778: 1776: 1764: 1756: 1754: 1753: 1732: 1731: 1727: 1696:(7517): S2–S3. 1683: 1682: 1675: 1631: 1630: 1613: 1600: 1599: 1595: 1582:(12): 711–716. 1573: 1572: 1559: 1523: 1522: 1511: 1497: 1496: 1489: 1459: 1458: 1447: 1433: 1423: 1419: 1402: 1401: 1397: 1382: 1361: 1360: 1356: 1337:Cancer Research 1330: 1329: 1314: 1304: 1302: 1293: 1292: 1288: 1275: 1274: 1265: 1252: 1251: 1242: 1235: 1214: 1213: 1190: 1146: 1145: 1141: 1103: 1102: 1091: 1047: 1046: 1033: 997: 996: 983: 974: 972: 959: 958: 951: 937: 936: 923: 886:Cancer Research 879: 878: 874: 830: 829: 825: 818: 805: 804: 800: 790: 788: 783: 782: 778: 765: 764: 755: 750:. 2 April 2015. 742: 741: 737: 723: 722: 711: 706: 694: 620:malignant tumor 557: 495:intraperitoneal 488: 467: 429: 397: 372: 352: 339: 301: 292: 275: 78: 45: 42: 35: 28: 23: 22: 15: 12: 11: 5: 1818: 1816: 1808: 1807: 1802: 1792: 1791: 1787: 1786: 1774: 1752: 1751: 1725: 1703:10.1038/513S2a 1673: 1644:(4): 217–222. 1611: 1593: 1557: 1536:(6): 665–668. 1509: 1487: 1468:(1–2): 83–90. 1445: 1417: 1395: 1380: 1354: 1312: 1286: 1263: 1240: 1233: 1188: 1139: 1089: 1031: 1010:(3): 294–300. 1004:Cancer Control 981: 949: 921: 872: 843:(2): 161–170. 837:Cancer Letters 823: 816: 798: 776: 753: 735: 708: 707: 705: 702: 701: 700: 693: 690: 689: 688: 681: 667: 660: 653: 642: 641: 634: 626: 556: 553: 533:covalent bonds 487: 484: 466: 463: 447:singlet oxygen 428: 427:Photoradiation 425: 396: 393: 371: 368: 351: 348: 338: 335: 300: 297: 291: 288: 274: 271: 171: 170: 167: 163: 162: 159: 155: 154: 153:, hyperthermia 144: 140: 139: 134: 128: 127: 121: 115: 114: 108: 102: 101: 96: 90: 89: 75: 74: 66: 65: 56: 52: 51: 43: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 1817: 1806: 1803: 1801: 1798: 1797: 1795: 1785: 1775: 1773: 1768: 1763: 1759: 1747: 1743: 1739: 1735: 1729: 1726: 1721: 1717: 1713: 1709: 1704: 1699: 1695: 1691: 1687: 1680: 1678: 1674: 1669: 1665: 1660: 1655: 1651: 1647: 1643: 1639: 1635: 1628: 1626: 1624: 1622: 1620: 1618: 1616: 1612: 1607: 1603: 1597: 1594: 1589: 1585: 1581: 1577: 1570: 1568: 1566: 1564: 1562: 1558: 1553: 1549: 1544: 1539: 1535: 1531: 1527: 1520: 1518: 1516: 1514: 1510: 1505: 1501: 1494: 1492: 1488: 1483: 1479: 1475: 1471: 1467: 1463: 1456: 1454: 1452: 1450: 1446: 1441: 1428: 1420: 1418:9780123749949 1414: 1410: 1406: 1399: 1396: 1391: 1387: 1383: 1381:9780128031193 1377: 1373: 1369: 1365: 1358: 1355: 1350: 1346: 1342: 1338: 1334: 1327: 1325: 1323: 1321: 1319: 1317: 1313: 1300: 1296: 1290: 1287: 1282: 1278: 1272: 1270: 1268: 1264: 1259: 1255: 1249: 1247: 1245: 1241: 1236: 1230: 1226: 1222: 1218: 1211: 1209: 1207: 1205: 1203: 1201: 1199: 1197: 1195: 1193: 1189: 1184: 1180: 1176: 1172: 1167: 1162: 1158: 1154: 1150: 1143: 1140: 1135: 1131: 1127: 1123: 1119: 1115: 1111: 1107: 1100: 1098: 1096: 1094: 1090: 1085: 1081: 1076: 1071: 1067: 1063: 1059: 1055: 1051: 1044: 1042: 1040: 1038: 1036: 1032: 1027: 1023: 1018: 1013: 1009: 1005: 1001: 994: 992: 990: 988: 986: 982: 971:on 2020-11-30 970: 966: 962: 956: 954: 950: 945: 941: 934: 932: 930: 928: 926: 922: 917: 913: 908: 903: 899: 895: 891: 887: 883: 876: 873: 868: 864: 859: 854: 850: 846: 842: 838: 834: 827: 824: 819: 813: 809: 802: 799: 786: 780: 777: 772: 768: 762: 760: 758: 754: 749: 745: 739: 736: 731: 727: 720: 718: 716: 714: 710: 703: 699: 696: 695: 691: 687: 686: 682: 679: 678: 673: 672: 668: 666: 665: 661: 659: 658: 654: 652: 651: 647: 646: 645: 640: 639: 635: 633: 632: 627: 625: 621: 617: 613: 610: 609: 608: 606: 601: 599: 595: 591: 587: 583: 579: 575: 574:breast cancer 570: 565: 561: 554: 552: 550: 546: 542: 538: 534: 530: 526: 524: 521:problems and 520: 516: 511: 506: 504: 500: 496: 492: 485: 483: 481: 477: 476:cell membrane 473: 472:nucleic acids 464: 462: 459: 457: 453: 448: 444: 440: 435: 433: 426: 424: 420: 416: 414: 409: 407: 401: 394: 392: 389: 385: 381: 377: 369: 367: 365: 361: 357: 349: 347: 345: 336: 334: 332: 328: 323: 318: 314: 310: 305: 298: 296: 289: 287: 285: 279: 272: 270: 267: 263: 259: 254: 252: 248: 244: 240: 236: 232: 228: 223: 220: 216: 211: 209: 207: 206: 200: 195: 193: 189: 185: 181: 177: 168: 164: 160: 156: 152: 148: 145: 141: 138: 135: 133: 129: 126: 122: 120: 116: 113: 109: 107: 103: 100: 97: 95: 91: 86: 82: 76: 72: 67: 64: 60: 57: 53: 48: 40: 33: 19: 1745: 1728: 1693: 1689: 1641: 1637: 1605: 1596: 1579: 1575: 1533: 1529: 1503: 1465: 1461: 1436:|title= 1398: 1363: 1357: 1340: 1336: 1303:. Retrieved 1298: 1289: 1280: 1257: 1216: 1156: 1152: 1142: 1112:(1): 49–64. 1109: 1105: 1060:(1): 27–41. 1057: 1053: 1007: 1003: 973:. Retrieved 969:the original 964: 943: 889: 885: 875: 840: 836: 826: 807: 801: 789:. Retrieved 779: 770: 747: 738: 729: 683: 675: 669: 662: 655: 648: 643: 636: 628: 619: 615: 611: 602: 600:malignancy. 566: 562: 558: 555:Epidemiology 541:nitrosoureas 527: 507: 491:Chemotherapy 489: 486:Chemotherapy 480:cytoskeleton 468: 465:Hyperthermia 460: 452:nucleic acid 436: 430: 421: 417: 410: 402: 398: 388:hyperthermia 376:chemotherapy 373: 353: 340: 337:Risk factors 322:Inflammation 315:and similar 302: 293: 280: 276: 255: 224: 218: 215:benign tumor 212: 204: 203: 198: 196: 187: 183: 175: 174: 151:chemotherapy 119:Risk factors 84: 80: 61:, malignant 582:lung cancer 503:intravenous 499:intrathecal 149:, surgery, 112:weight loss 55:Other names 1794:Categories 975:2021-05-31 704:References 629:Malignant 612:Malignancy 590:colorectal 549:aziridines 545:tetrazines 443:carcinomas 370:Management 331:epithelial 247:epigenetic 231:metastasis 178:(from 176:Malignancy 50:Malignancy 1738:Ritchie H 1427:cite book 607:include: 569:leukaemia 439:melanomas 380:radiation 317:pathogens 258:mammogram 251:microRNAs 227:anaplasia 199:malignant 158:Frequency 143:Treatment 94:Specialty 1805:Oncology 1784:Medicine 1742:"Cancer" 1740:(2015). 1712:25208070 1668:31854162 1576:Medicine 1552:19721789 1482:10421511 1390:26233903 1305:23 April 1183:40192165 1175:20659094 1134:53756320 1126:30471741 1084:31315034 1054:Immunity 1026:10758560 916:23002210 867:23178448 767:"Cancer" 692:See also 605:oncology 523:alopecia 384:surgical 309:Bacteria 299:Triggers 262:MRI test 106:Symptoms 99:Oncology 63:neoplasm 1772:Biology 1758:Portals 1734:Roser M 1659:7310786 1543:2684058 1217:Surgery 1075:6831096 907:3712191 858:3622788 631:ascites 594:stomach 395:Surgery 325:tumour 1720:577152 1718:  1710:  1690:Nature 1666:  1656:  1550:  1540:  1480:  1415:  1388:  1378:  1349:667856 1347:  1301:. 2021 1231:  1181:  1173:  1132:  1124:  1082:  1072:  1024:  914:  904:  865:  855:  814:  791:23 May 624:cancer 501:(IT), 497:(IP), 413:biopsy 290:Causes 266:biopsy 260:or an 219:benign 205:benign 192:cancer 166:Deaths 137:Biopsy 59:Cancer 1716:S2CID 1179:S2CID 1130:S2CID 598:liver 578:liver 576:with 313:fungi 208:tumor 188:-gnus 182: 180:Latin 81:right 1708:PMID 1664:PMID 1548:PMID 1478:PMID 1440:help 1413:ISBN 1386:PMID 1376:ISBN 1345:PMID 1307:2021 1229:ISBN 1171:PMID 1122:PMID 1080:PMID 1022:PMID 912:PMID 863:PMID 812:ISBN 793:2023 618:and 596:and 586:lung 580:and 547:and 478:and 454:and 441:and 382:and 284:lump 184:male 85:left 1698:doi 1694:513 1654:PMC 1646:doi 1584:doi 1538:PMC 1470:doi 1405:doi 1368:doi 1221:doi 1161:doi 1114:doi 1070:PMC 1062:doi 1012:doi 902:PMC 894:doi 853:PMC 845:doi 841:340 551:." 1796:: 1744:. 1736:; 1714:. 1706:. 1692:. 1688:. 1676:^ 1662:. 1652:. 1640:. 1636:. 1614:^ 1604:. 1580:39 1578:. 1560:^ 1546:. 1534:50 1532:. 1528:. 1512:^ 1502:. 1490:^ 1476:. 1464:. 1448:^ 1431:: 1429:}} 1425:{{ 1411:. 1384:. 1374:. 1341:38 1339:. 1335:. 1315:^ 1297:. 1279:. 1266:^ 1256:. 1243:^ 1227:. 1191:^ 1177:. 1169:. 1157:10 1155:. 1151:. 1128:. 1120:. 1110:99 1108:. 1092:^ 1078:. 1068:. 1058:51 1056:. 1052:. 1034:^ 1020:. 1006:. 1002:. 984:^ 963:. 952:^ 942:. 924:^ 910:. 900:. 890:72 888:. 884:. 861:. 851:. 839:. 835:. 769:. 756:^ 746:. 728:. 712:^ 614:, 592:, 588:, 543:, 517:, 474:, 378:, 346:. 311:, 213:A 197:A 194:. 1760:: 1748:. 1722:. 1700:: 1670:. 1648:: 1642:9 1608:. 1590:. 1586:: 1554:. 1506:. 1484:. 1472:: 1466:7 1442:) 1438:( 1421:. 1407:: 1392:. 1370:: 1351:. 1309:. 1283:. 1237:. 1223:: 1185:. 1163:: 1136:. 1116:: 1086:. 1064:: 1028:. 1014:: 1008:6 978:. 946:. 918:. 896:: 869:. 847:: 820:. 795:. 732:. 680:) 41:. 34:. 20:)

Index

Malignant disease
Malignancy (band)
Malignant (disambiguation)
Cancer
neoplasm

Specialty
Oncology
Symptoms
weight loss
Risk factors
infectious diseases
Diagnostic method
Biopsy
Photoradiation therapy
chemotherapy
Latin
cancer
benign tumor
benign tumor
anaplasia
metastasis
genome instability
whole genome sequencing
tumour heterogeneity
epigenetic
microRNAs
mammogram
MRI test
biopsy

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.